The settlement will be a primary part of the investigation as it moves forward, investigators said at a meeting Wednesday.
The Massachusetts Gaming Commission announced Sunday that it's reviewing the license it issued for Wynn Boston Harbor, a $2.1 billion casino and hotel project set to open in 2019. The commission could ultimately decide to alter, suspend or revoke the license as a result.
The probe follows a Wall Street Journal investigation published last week that detailed decades of sexual misconduct allegations against Wynn, the 76-year-old founder and CEO of Wynn Resorts (WYNN).
Wynn has denied all the charges against him, calling them "preposterous."
Karen Wells, director of the commission's investigations team, said Wednesday that during the state's "suitability" review of both Wynn and Wynn Resorts, no one disclosed a $7.5 million settlement that had been paid to a manicurist over sexual misconduct claims she made in 2005.
Hot Casino Stocks For 2019: Nabriva Therapeutics AG(NBRV)
Advisors' Opinion:- [By Logan Wallace]
Nabriva Therapeutics PLC – (NASDAQ:NBRV) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 1,574,112 shares, a growth of 28.5% from the August 15th total of 1,224,631 shares. Currently, 3.4% of the company’s stock are short sold. Based on an average daily trading volume, of 315,802 shares, the short-interest ratio is currently 5.0 days.
- [By Ethan Ryder]
Nabriva Therapeutics (NASDAQ:NBRV) last issued its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.36) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.59) by $0.23. Nabriva Therapeutics had a negative return on equity of 79.30% and a negative net margin of 600.34%. The firm had revenue of $7.55 million for the quarter, compared to analyst estimates of $1.27 million. equities analysts anticipate that Nabriva Therapeutics will post -1.9 EPS for the current fiscal year.
- [By Lisa Levin]
Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) were down 14 percent to $4.6666 despite positive topline results from Phase 3 Lefamulin trial.
Carver Bancorp, Inc. (NASDAQ: CARV) was down, falling around 21 percent to $6.59 after surging 201.37 percent on Thursday.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Nabriva Therapeutics (NBRV)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Nabriva Therapeutics (NASDAQ:NBRV) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Tuesday.
- [By Ethan Ryder]
Nabriva Therapeutics PLC – (NASDAQ:NBRV) – Analysts at Wedbush boosted their Q2 2018 earnings per share estimates for Nabriva Therapeutics in a research note issued to investors on Monday, July 30th. Wedbush analyst R. Driscoll now forecasts that the biotechnology company will post earnings per share of ($0.44) for the quarter, up from their prior estimate of ($0.46). Wedbush also issued estimates for Nabriva Therapeutics’ Q3 2018 earnings at ($0.17) EPS, Q4 2018 earnings at ($0.26) EPS, FY2018 earnings at ($1.24) EPS, FY2019 earnings at ($1.11) EPS, FY2020 earnings at ($0.66) EPS, FY2021 earnings at ($0.24) EPS and FY2022 earnings at $0.52 EPS.
Hot Casino Stocks For 2019: Magyar Bancorp Inc.(MGYR)
Advisors' Opinion:- [By Ethan Ryder]
Media headlines about Magyar Bancorp (NASDAQ:MGYR) have been trending somewhat positive on Friday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Magyar Bancorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 48.0770691063571 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Hot Casino Stocks For 2019: Texas Roadhouse, Inc.(TXRH)
Advisors' Opinion:- [By Chris Hill]
The roundup for today's MarketFoolery includes Tesla (NASDAQ:TSLA), Texas Roadhouse (NASDAQ:TXRH), some general investing advice, and an international growth story that deserves more attention. Tesla's C-Suite revolving-door drama continues, and this departure is especially concerning. Texas Roadhouse has been quietly knocking it out of the park for years, but the market doesn't seem to care about yet another stellar report this week.
- [By Stephan Byrd]
BidaskClub lowered shares of Texas Roadhouse (NASDAQ:TXRH) from a strong-buy rating to a buy rating in a report issued on Saturday.
Other analysts have also recently issued reports about the company. BTIG Research boosted their price target on Texas Roadhouse to $67.00 and gave the stock a reduce rating in a research report on Tuesday, January 16th. Maxim Group reiterated a buy rating and set a $65.00 price target (up from $60.00) on shares of Texas Roadhouse in a research report on Wednesday, January 24th. JPMorgan Chase cut Texas Roadhouse from a neutral rating to an underweight rating and set a $54.00 price target for the company. in a research report on Wednesday, May 2nd. Telsey Advisory Group reiterated a market perform rating and set a $64.00 price target (up from $58.00) on shares of Texas Roadhouse in a research report on Thursday, February 15th. Finally, Barclays boosted their price target on Texas Roadhouse from $62.00 to $63.00 and gave the stock an overweight rating in a research report on Wednesday, January 24th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have assigned a buy rating to the company’s stock. Texas Roadhouse currently has a consensus rating of Hold and an average price target of $61.46.
- [By Nicholas Rossolillo]
Savvy investors looking for income know that high yields aren't the whole story. A company that consistently increases its dividend can be even better to own as share prices tend to follow that dividend higher. To help with the search for a great payday, check out shares of Texas Roadhouse (NASDAQ:TXRH), TJX Companies (NYSE:TJX), and Apple (NASDAQ:AAPL).
- [By Nicholas Rossolillo]
Texas-themed steakhouse chain Texas Roadhouse (NASDAQ:TXRH) just reported another solid quarter. The spring of 2018 was a busy one for the small-town America restaurant, with foot traffic continuing to edge higher and a few new store openings getting a warm reception from diners.
- [By Stephan Byrd]
Texas Roadhouse Inc (NASDAQ:TXRH) – Equities researchers at Jefferies Financial Group upped their Q2 2019 earnings per share (EPS) estimates for shares of Texas Roadhouse in a research report issued to clients and investors on Tuesday, February 19th. Jefferies Financial Group analyst A. Barish now forecasts that the restaurant operator will post earnings of $0.70 per share for the quarter, up from their previous forecast of $0.69. Jefferies Financial Group also issued estimates for Texas Roadhouse’s Q4 2019 earnings at $0.47 EPS, FY2019 earnings at $2.46 EPS, Q1 2020 earnings at $0.93 EPS, Q2 2020 earnings at $0.82 EPS, Q3 2020 earnings at $0.59 EPS, Q4 2020 earnings at $0.55 EPS and FY2020 earnings at $2.89 EPS.
Hot Casino Stocks For 2019: Hudson Global, Inc.(HSON)
Advisors' Opinion:- [By Shane Hupp]
JBF Capital Inc. purchased a new position in Hudson Global Inc (NASDAQ:HSON) in the second quarter, Holdings Channel reports. The fund purchased 157,917 shares of the business services provider’s stock, valued at approximately $256,000.
No comments:
Post a Comment